BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1279 related articles for article (PubMed ID: 31291966)

  • 1. Neuroinflammation: friend and foe for ischemic stroke.
    Jayaraj RL; Azimullah S; Beiram R; Jalal FY; Rosenberg GA
    J Neuroinflammation; 2019 Jul; 16(1):142. PubMed ID: 31291966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
    Lopes Pinheiro MA; Kooij G; Mizee MR; Kamermans A; Enzmann G; Lyck R; Schwaninger M; Engelhardt B; de Vries HE
    Biochim Biophys Acta; 2016 Mar; 1862(3):461-71. PubMed ID: 26527183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches.
    Shekhar S; Cunningham MW; Pabbidi MR; Wang S; Booz GW; Fan F
    Eur J Pharmacol; 2018 Aug; 833():531-544. PubMed ID: 29935175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroinflammation in Post-Ischemic Neurodegeneration of the Brain: Friend, Foe, or Both?
    Pluta R; Januszewski S; Czuczwar SJ
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent dual effect of microglia in ischemic stroke.
    Fan PL; Wang SS; Chu SF; Chen NH
    Neurochem Int; 2023 Oct; 169():105584. PubMed ID: 37454817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pivotal role of innate myeloid cells in cerebral post-ischemic sterile inflammation.
    Tsuyama J; Nakamura A; Ooboshi H; Yoshimura A; Shichita T
    Semin Immunopathol; 2018 Nov; 40(6):523-538. PubMed ID: 30206661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remote Postischemic Conditioning Promotes Stroke Recovery by Shifting Circulating Monocytes to CCR2
    Yang J; Balkaya M; Beltran C; Heo JH; Cho S
    J Neurosci; 2019 Sep; 39(39):7778-7789. PubMed ID: 31427395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pivotal neuroinflammatory and therapeutic role of high mobility group box 1 in ischemic stroke.
    Richard SA; Sackey M; Su Z; Xu H
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroinflammatory Mechanisms in Ischemic Stroke: Focus on Cardioembolic Stroke, Background, and Therapeutic Approaches.
    Maida CD; Norrito RL; Daidone M; Tuttolomondo A; Pinto A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGB1 as a Key Mediator of Immune Mechanisms in Ischemic Stroke.
    Singh V; Roth S; Veltkamp R; Liesz A
    Antioxid Redox Signal; 2016 Apr; 24(12):635-51. PubMed ID: 26493086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TARGETING NEUROINFLAMMATION FOR TREATMENT OF ISCHEMIC STROKE.
    Kokaia Z
    Georgian Med News; 2015 Jun; (243):84-7. PubMed ID: 26087739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid cells as therapeutic targets in neuroinflammation after stroke: Specific roles of neutrophils and neutrophil-platelet interactions.
    García-Culebras A; Durán-Laforet V; Peña-Martínez C; Ballesteros I; Pradillo JM; Díaz-Guzmán J; Lizasoain I; Moro MA
    J Cereb Blood Flow Metab; 2018 Dec; 38(12):2150-2164. PubMed ID: 30129391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics.
    Candelario-Jalil E
    Curr Opin Investig Drugs; 2009 Jul; 10(7):644-54. PubMed ID: 19579170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Insight Into Neutrophils: A Potential Therapeutic Target for Cerebral Ischemia.
    Chen R; Zhang X; Gu L; Zhu H; Zhong Y; Ye Y; Xiong X; Jian Z
    Front Immunol; 2021; 12():692061. PubMed ID: 34335600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGB1: A New Target for Ischemic Stroke and Hemorrhagic Transformation.
    Li J; Wang Z; Li J; Zhao H; Ma Q
    Transl Stroke Res; 2024 May; ():. PubMed ID: 38740617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Involvement and Therapy Target of Immune Cells After Ischemic Stroke.
    Jian Z; Liu R; Zhu X; Smerin D; Zhong Y; Gu L; Fang W; Xiong X
    Front Immunol; 2019; 10():2167. PubMed ID: 31572378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory responses in brain ischemia.
    Kawabori M; Yenari MA
    Curr Med Chem; 2015; 22(10):1258-77. PubMed ID: 25666795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets.
    Kim JY; Kawabori M; Yenari MA
    Curr Med Chem; 2014; 21(18):2076-97. PubMed ID: 24372209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The extracellular matrix as modifier of neuroinflammation and recovery in ischemic stroke and intracerebral hemorrhage.
    Li H; Ghorbani S; Ling CC; Yong VW; Xue M
    Neurobiol Dis; 2023 Oct; 186():106282. PubMed ID: 37683956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells.
    Jin R; Yang G; Li G
    J Leukoc Biol; 2010 May; 87(5):779-89. PubMed ID: 20130219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.